Skin lesion's treatment with alfa interferon in a patient with B-CLL

K Panteli1, K H Katsanos, M Kitsanou

  • 1Haematology Unit, Medical School, University of Ioannina, Greece.

Treatment with recombinant alfa-2b-interferon in a patient with advanced B-CLL resulting in complete remission of skin lesions after one month therapy is reported in this paper. Interferon was administered subcutaneously three times weekly. Six months later while the treatment continued, the disease remained stable.

Related Concept Videos